TRAF6, TNF receptor associated factor 6, 7189

N. diseases: 254; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 Biomarker disease BEFREE TNF receptor-associated factor 6 (TRAF6) promotes the development of human lung cancer through bridging RAS and NF-kB pathways; on the other hand, thioredoxin-interacting protein (TXNIP) suppresses the growth of tumors. 31578830 2019
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 GeneticVariation disease BEFREE Thus, miR-146a rs2910164 polymorphism may influence susceptibility to lung cancer in Chinese nonsmoking females through targeting TRAF6. 27911870 2017
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 AlteredExpression disease BEFREE The expression of TRAF6 was determined in human lung adenocarcinoma A549, non-small cell lung cancer H1650, human airway epithelial Calu-3 and human lung cancer SPC-A1 cell lines using quantitative RT-PCR (qRT‑PCR) and western blotting at the transcriptional and translational levels. 26847475 2016
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 AlteredExpression disease BEFREE Results indicated that TRAF6 displayed an upregulation in human lung cancer cell lines. 23055197 2013
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 Biomarker disease BEFREE Inhibition of TRAF6 in human lung cancer cell lines suppressed NF-κB activation, anchorage-independent growth, and tumor formation. 21911935 2011